High‐intensity focused ultrasound: Safety and efficacy of a novel treatment modality for neurofibromatosis type 1 cutaneous neurofibroma.

Autor: Peltonen, Sirkku^1,2,3,4 (AUTHOR) sirkku.peltonen@gu.se, Serup, Jørgen⁵ (AUTHOR), Tang, Mimmi^1,2 (AUTHOR), Gillstedt, Martin^1,2 (AUTHOR), Kantere, Despoina^1,2 (AUTHOR), Neittaanmäki, Noora^6,7 (AUTHOR), Holmström, Peter¹ (AUTHOR), Blakeley, Jaishri O.⁸ (AUTHOR), Rosner, Karli⁸ (AUTHOR), Roberts, Joshua⁸ (AUTHOR), Bove, Torsten⁹ (AUTHOR), Karmisholt, Katrine Elisabeth⁵ (AUTHOR)

Publikováno v: JEADV Clinical Practice. Sep2024, Vol. 3 Issue 4, p1049-1060. 12p.

Risk behaviour and patient preferences for an improved non-melanoma skin cancer prevention modality for organ-transplanted patients: a European, multi-country, online patient community study.

Autor: Basset Seguin N; Service de Dermatologie, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, 75010 Paris, France - Université Paris 7, 10 avenue de Verdun, 75010 Paris, France., Malvehy J; Dermatology Department. Hospital Clínic de Barcelona, IDIBAPS, Carrer de Villarroel, 170, 08036, Barcelona, Spain-Universitat de Barcelona, Carrer de Casanova, 143, 08036 Barcelona, Spain., Nadal F; Pierre Fabre Laboratories, Dermatology innovation unit, Centre de Recherche et Développement, 3, avenue Hubert Curien - BP 13652, 31035 Toulouse, France., Creancier L; Pierre Fabre Laboratories, Dermatology innovation unit, Centre de Recherche et Développement, 3, avenue Hubert Curien - BP 13652, 31035 Toulouse, France., Rauly-Lestienne I; Pierre Fabre Laboratories, Dermatology innovation unit, Centre de Recherche et Développement, 3, avenue Hubert Curien - BP 13652, 31035 Toulouse, France., Beauchamp R; Pierre Fabre Laboratories, Dermatology innovation unit, Centre de Recherche et Développement, 3, avenue Hubert Curien - BP 13652, 31035 Toulouse, France., Hezareh M; Pierre Fabre Laboratories, Dermatology innovation unit, Centre de Recherche et Développement, 3, avenue Hubert Curien - BP 13652, 31035 Toulouse, France., Schmitt AM; Pierre Fabre Laboratories, Dermatology innovation unit, Centre de Recherche et Développement, 3, avenue Hubert Curien - BP 13652, 31035 Toulouse, France., Ulianov L; Pierre Fabre Laboratories, Dermatology innovation unit, Centre de Recherche et Développement, 3, avenue Hubert Curien - BP 13652, 31035 Toulouse, France.

Publikováno v: European journal of dermatology : EJD [Eur J Dermatol] 2019 Oct 01; Vol. 29 (5), pp. 518-523.

Contribution of muscarinic receptors to in vitro and in vivo effects of Ruscus extract.

Autor: Rauly-Lestienne I; Centre de Recherche Pierre Fabre, 17 Av. Jean Moulin, 81100 Castres, France., Heusler P; Centre de Recherche Pierre Fabre, 17 Av. Jean Moulin, 81100 Castres, France., Cussac D; Centre de Recherche Pierre Fabre, 17 Av. Jean Moulin, 81100 Castres, France., Lantoine-Adam F; Centre de Recherche Pierre Fabre, 17 Av. Jean Moulin, 81100 Castres, France., de Almeida Cyrino FZG; Laboratory for Clinical and Experimental Research on Vascular Biology (BioVasc), Biomedical Center, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Bouskela E; Laboratory for Clinical and Experimental Research on Vascular Biology (BioVasc), Biomedical Center, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: eliete.bouskela@gmail.com.

Publikováno v: Microvascular research [Microvasc Res] 2017 Nov; Vol. 114, pp. 1-11. Date of Electronic Publication: 2017 May 19.

Impact of neurofibromatosis type 1 on quality of life using the Skindex-29 questionnaire quality of life in NF1.

Autor: Cieza Rivera, Ana M.¹ (AUTHOR), Lobato Fuertes, Carlos² (AUTHOR), Fernández-Villa, Tania^1,3,4 (AUTHOR), Martín Sánchez, Vicente^1,3,4 (AUTHOR), Atallah, Isis^1,5 (AUTHOR) maria-isis.atallah-gonzalez@chuv.ch

Publikováno v: Orphanet Journal of Rare Diseases. 2/24/2024, Vol. 19 Issue 1, p1-9. 9p.

Pharmacological evaluation of a series of smoothened antagonists in signaling pathways and after topical application in a depilated mouse model.

Autor: Lauressergues E; Department of Cellular and Molecular Biology Pierre Fabre Research Centre 17, avenue Jean Moulin F-81106 Castres Cedex France., Heusler P; Department of Cellular and Molecular Biology Pierre Fabre Research Centre 17, avenue Jean Moulin F-81106 Castres Cedex France., Lestienne F; Department of Cellular and Molecular Biology Pierre Fabre Research Centre 17, avenue Jean Moulin F-81106 Castres Cedex France., Troulier D; Department of Developability Pierre Fabre Research Centre Castres France., Rauly-Lestienne I; Department of Cellular and Molecular Biology Pierre Fabre Research Centre 17, avenue Jean Moulin F-81106 Castres Cedex France., Tourette A; Department of Cellular and Molecular Biology Pierre Fabre Research Centre 17, avenue Jean Moulin F-81106 Castres Cedex France., Ailhaud MC; Department of Cellular and Molecular Biology Pierre Fabre Research Centre 17, avenue Jean Moulin F-81106 Castres Cedex France., Cathala C; Department of Cellular and Molecular Biology Pierre Fabre Research Centre 17, avenue Jean Moulin F-81106 Castres Cedex France., Tardif S; Department of Cellular and Molecular Biology Pierre Fabre Research Centre 17, avenue Jean Moulin F-81106 Castres Cedex France., Denais-Laliève D; Laboratory Animal Resources Pierre Fabre Research Centre Castres France., Calmettes MT; Laboratory Animal Resources Pierre Fabre Research Centre Castres France., Degryse AD; Laboratory Animal Resources Pierre Fabre Research Centre Castres France., Dumoulin A; Department of Developability Pierre Fabre Research Centre Castres France., De Vries L; Department of Cellular and Molecular Biology Pierre Fabre Research Centre 17, avenue Jean Moulin F-81106 Castres Cedex France., Cussac D; Department of Cellular and Molecular Biology Pierre Fabre Research Centre 17, avenue Jean Moulin F-81106 Castres Cedex France.

Publikováno v: Pharmacology research & perspectives [Pharmacol Res Perspect] 2016 Mar 04; Vol. 4 (2), pp. e00214. Date of Electronic Publication: 2016 Mar 04 (Print Publication: 2016).